AMR Action Fund Announces Investment in BioVersys AG
By asianet
— Deal marks Fund’s first investment in Europe and advances its mission of enabling the launch of two to four antimicrobials by 2030 The AMR Action Fund, the world’s largest public-private partnership investing in biotech companies that are developing antimicrobials, announced today that it has invested in BioVersys AG, a clinical-stage company based in Basel, … Continued